Atlas Trials

Stage III Bladder Cancer AJCC v8

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage III Bladder Cancer AJCC v8

RecordFirmDate
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study (NCT05092958)National Cancer Institute (NCI)2022-06-03
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)M.D. Anderson Cancer Center2021-09-23
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies (NCT04902040)M.D. Anderson Cancer Center2021-04-14
A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial (NCT04216290)National Cancer Institute (NCI)2021-03-17
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes (NCT03375307)National Cancer Institute (NCI)2020-11-03
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)City of Hope Medical Center2019-12-24
Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma (NCT03854474)National Cancer Institute (NCI)2019-11-18
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952)National Cancer Institute (NCI)2019-06-05
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer (NCT03617913)Mayo Clinic2018-09-19
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780)National Cancer Institute (NCI)2018-07-20
Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT03319745)M.D. Anderson Cancer Center2018-01-11
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208)National Cancer Institute (NCI)2015-07-22

Track Stage III Bladder Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.